PPS for the prevention of potential adverse effects caused by CD3 specific binding domains
申请人:AMGEN RESEARCH (MUNICH) GMBH
公开号:US20140228316A1
公开(公告)日:2014-08-14
The present invention relates to a PPS for use in the amelioration, treatment or prophylaxis of neurological adverse events caused by a CD3 binding domain. Kits comprising a PPS, a CD3 binding domain and instructions for use which indicate that the PPS is to be employed for the treatment amelioration and/or prophylaxis of neurological adverse events caused by said CD3 binding domain, are also disclosed.